Agreed, and that's what Matt said too. Paraphrasing here now, but something like "we are not interested in doing the usual ASX surge and dump in SP", this will only benefit traders, not LTH's. He is building a commercially viable company which will be reflected in a high stable SP based on real earnings.
Bring on the FDA sign off on SB next year and we'll see what the SP is then.
Ann: Positive BTX 1702 Phase 1b/2 Clinical Study for Rosacea, page-51
-
- There are more pages in this discussion • 50 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
42.0¢ |
Change
0.005(1.20%) |
Mkt cap ! $742.1M | |||
| Open | High | Low | Value | Volume |
| 42.0¢ | 43.0¢ | 40.5¢ | $1.221M | 2.937M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 321715 | 41.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 42.0¢ | 216238 | 8 |
View Market Depth
| Last trade - 11.20am 03/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |